iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
2,450
(1.93%)
Apr 29, 2026|02:54:58 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,700₹2.75 0%7500%
--1,800₹6.9 0%3,7500%
--1,880₹9.05 0%2,6250%
--1,900₹6.85 0%13,1250%
7500%₹480 0%1,920--
--1,940₹11.6 0%1,1250%
24,7500%₹430 0%2,000₹8.8 0%40,8750%
--2,020₹21.1 0%1,5000%
--2,040₹9 -18.55%10,500366.66%
--2,060₹28.8 3.59%1,1250%
7,8750%₹276.6 0%2,080₹12.9 0%1,8750%
6,0000%₹260.95 0%2,100₹11.6 -19.44%67,500-6.25%
3750%₹222.1 0%2,120₹36.1 0%1,8750%
1,1250%₹222 0%2,140₹18.25 0%14,2500%
--2,160₹16 -23.62%16,8750%
--2,180₹23.3 0%4,5000%
53,6250.70%₹283 16.84%2,200₹21.7 -18.26%1,08,3753.95%
00%₹118 0%2,220₹33.1 0%3750%
21,3750%₹222 0%2,240₹33.5 -1.17%9,0000%
10,8750%₹240 20.39%2,260₹31 -20.1%21,375-6.55%
19,1250%₹120.65 0%2,280₹42.9 -2.38%15,0000%
1,16,625-0.63%₹201.15 19.58%2,300₹40.6 -17.89%1,51,8756.57%
22,1250%₹201.4 32.5%2,320₹45.45 -18.83%27,0002.85%
48,7500.77%₹187.25 32.14%2,340₹52 -18.62%25,12519.64%
42,375156.81%₹160 22.27%2,360₹58.65 -17.04%39,37522.09%
12,375-40%₹150.6 25.44%2,380₹60 -23.46%20,6250%
2,86,125-10.23%₹135.85 24.8%2,400₹72 -18.27%1,02,75021.77%
67,125-21.83%₹126.15 28.26%2,420₹81.4 -17.52%21,75041.46%
99,375115.44%₹114 27.44%2,440--
46,50056.96%₹102.5 27.56%2,460--
28,50013.43%₹95.95 31.43%2,480--
1,94,62512.09%₹84.95 31.19%2,500₹118.95 -20.48%6,7505.88%
26,2509.37%₹76.85 32.95%2,520--
5,2500%₹52.1 0.19%2,540--
31,87510.38%₹63.5 36.41%2,560₹275.1 0%9,3750%
9,7500%₹57 40.74%2,580--
88,875-3.26%₹50 36.98%2,600₹185.7 -9.7%4,50020%
3,7500%₹47 21.76%2,620--
1,8750%₹42 25%2,640--
7,125-5%₹35.95 41.53%2,660--
64,50010.96%₹32 42.85%2,680--
1,8750%₹24.5 0%2,720--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.